Event Date and Time
-
Location
Online Live Webinar
On December 7th, from 11:00am-12:30pm PST (2:00PM-3:00PM EST), a webinar training event will be available for all providers. Below is an overview of the webinar training and registration is available here.
Overview: Opioid overdose is a leading cause of injury-related death in the United States, as well as a major risk at the termination of any treatment for opioid use disorder. The response to the opioid epidemic has largely focused on primary care and other medical professions prescribing practices, along with increased support for opioid use disorder treatment. Although the Centers for Disease Control and Prevention recommends naloxone co-prescription and the Substance Abuse and Mental Health Services Administration recommends provision of take-home naloxone to any patients completing treatment off of medications, these practices remain uncommon.
This webinar will review the rationale for and history of lay naloxone provision, the evidence and research gaps, and potential logistic needs to provide naloxone in clinical settings, including substance use disorder treatment.
Learning Objectives:
The goals of this training are to:- Understand the risk of opioid overdose mortality upon completion of treatment for opioid use disorder
- Describe the rationale for providing naloxone to lay persons
- Describe the key evidence regarding the effects of naloxone provision
- Identify strategies for naloxone provision in clinical settings
- Identify challenges to adopting naloxone provision in clinical practice
Presenter:
Phillip O. Coffin, MD, MIA
Director of Substance Use Research, San Francisco Department of Public Health
Division of HIV, Infectious Disease & Global Health, University of California San Francisco
Phillip O. Coffin, MD, MIA
Director of Substance Use Research, San Francisco Department of Public Health
Division of HIV, Infectious Disease & Global Health, University of California San Francisco
